Dr Kalyanam Shivkumar Named New Editor of JACC: Clinical Electrophysiology

A specialist in interventional cardiac electrophysiology, Dr Kalyanam Shivkumar has developed several innovative techniques for the catheter ablation of cardiac arrhythmias and other cardiac interventions. His research work, both basic/translational and clinical, relates to mechanisms of cardiac arrhythmias in humans and the role of the autonomic nervous system in sudden cardiac death.

Shivkumar has been elected as a Fellow of the American College of Cardiology (FACC) and to the membership of the American Society of Clinical Investigation.

“It is a rare honor and a privilege to serve as the editor-in-chief of JACC: Clinical Electrophysiology,” Shivkumar said. “Our editorial team looks forward to seeking and publishing the very best science in the field of cardiac arrhythmias.”

Launched in 2015, JACC: Clinical Electrophysiology is a monthly subspecialty journal encompassing all aspects of the epidemiology, pathogenesis, diagnosis and treatment of cardiac arrhythmias. The journal occupies a unique position by focusing primarily on the practicing clinical electrophysiologist’s need for context and critical information to direct therapeutic decision making. It aims to publish only the highest caliber papers and authors, focusing on content that advances the field.

Shivkumar’s first issue of JACC: Clinical Electrophysiology will publish in July 2020.


Other non-profit news.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.